🇨🇦 Pharmacotherapy to slow and control ventricular rate in Canada

Pharmacotherapy to slow and control ventricular rate (Pharmacotherapy to slow and control ventricular rate) regulatory status in Canada.

Marketing authorisation

Pharmacotherapy to slow and control ventricular rate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pharmacotherapy to slow and control ventricular rate approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Pharmacotherapy to slow and control ventricular rate in Canada?

National Institute of Cardiology, Warsaw, Poland is the originator. The local marketing authorisation holder may differ — check the official source linked above.